Our network AMR at Leeds is tackling the growing global crisis of resistance to antibiotics and other anti-infective drugs
What is AMR
Antimicrobial agents, such as antibiotics, are our primary means of treating infectious diseases in humans and animals. Unfortunately, these drugs are rapidly becoming less effective, as microbes evolve to resist their effects, a phenomenon referred to as antimicrobial resistance or AMR.
If we dont address AMR as a matter of urgency, over 300 million people worldwide are predicted to die prematurely by 2050.
Our research spans multiple disciplines in a coordinated effort to tackle AMR, focusing on eight key areas.
Why is antimicrobial resistance an urgent public health issue and how can research tackle it?
Read our Medium article highlighting three very different projects in healthcare settings in China, Pakistan and in communities in Nepal.
Events and activities
On 8 June, join Dr Laura Carter and Dr Marco-Filipe King to hear about AMR in our natural and built environments.
Connect with AMR at Leeds through our padlet board. Find out what areas people are working in and share your experience and expertise.